Treatment for High Functioning Depression

Many people arrive at residential treatment carrying two questions at once: “Is my drinking or drug use the problem?” and “Or is it depression, anxiety, or something else underneath?” Families ask the same thing at admission, often hoping for a clear answer on day one. In practice, a responsible program usually cannot give a final psychiatric diagnosis that early, and the reason is clinical, not bureaucratic. This post explains how co-occurring mental health conditions are evaluated during residential treatment, why the timing matters, and what to tell admissions so the evaluation starts on the right footing.

Why a Psychiatric Diagnosis Often Waits Until After Withdrawal

Alcohol, stimulants, opioids, cannabis and sedatives all change mood, sleep, appetite and concentration, both during heavy use and during withdrawal. Someone coming off methamphetamine can look severely depressed for days. Someone in early alcohol withdrawal can look like they have a panic disorder. Those symptoms are real and they are treated, but they do not yet tell a clinician whether an independent depressive or anxiety disorder exists.

When a diagnosis of depression can be separated from substance use: Under the DSM-5 diagnostic criteria, a depressive episode that starts during intoxication or withdrawal is generally classed as substance-induced, and clinicians look for symptoms that persist for a substantial period, about one month, after acute withdrawal or heavy intoxication ends before treating it as an independent disorder. A documented history of depression during earlier periods of sobriety also counts as evidence of an independent condition. That is why a residential program will usually describe early mood symptoms as provisional and revisit the diagnosis after the first few weeks of abstinence.

The paragraph above is the single most useful thing for families to understand. “We are watching it” in week one is not avoidance; it is how the diagnostic criteria are designed to work.

What Week One Actually Looks Like

The first week of residential care is usually dominated by sleep and physical stabilization. It is common for mood to dip partway through that first week, when the immediate relief of being in a safe place has worn off and the body is still recalibrating. Families who call during that window sometimes hear a loved one say “this isn’t working” or “I think I’ve always been depressed.” Both statements deserve to be taken seriously and passed on to staff, and both are common at that point in care.

By the second and third weeks, the picture often shifts. Sleep starts to regulate, appetite returns, and the person can engage in therapy groups with more focus. This is when clinicians get a clearer read on what is left once the substance effects have faded. For some people, the depression lifts substantially. For others, it stays put, and that persistence is itself diagnostic information.

Common Reasons Mood Symptoms Persist in Early Recovery

When low mood or anxiety continues past early withdrawal, clinicians typically consider several possibilities:

  • Independent depressive or anxiety disorder: A condition that existed before or alongside substance use and needs its own treatment plan.
  • Protracted withdrawal symptoms: Some people experience lingering sleep disturbance, irritability and low mood for weeks after stopping alcohol, opioids or benzodiazepines.
  • Trauma-related symptoms: Substance use sometimes masks post-traumatic stress symptoms that surface once the person is sober.
  • Grief and consequences: Lost relationships, legal problems and financial damage produce real sadness that is not always a disorder.
  • Medication effects or gaps: Psychiatric medications that were taken inconsistently during active use may need to be reassessed.

The National Institute on Drug Abuse (NIDA) describes substance use disorders and other mental illnesses as frequently occurring together and recommends that both be assessed and treated in an integrated way rather than one after the other. The National Institute of Mental Health (NIMH) makes a similar point about shared risk factors.

What Families Usually Notice First

Families often have the most valuable information in the room. They remember whether a loved one seemed withdrawn as a teenager before any drinking started, whether panic attacks came first or later, and whether there were long stretches of sobriety that were still hard emotionally. That timeline is exactly what a clinician needs to separate substance-induced symptoms from an independent disorder. Before the intake or family session, it helps to write down approximate dates rather than relying on memory in the moment.

Psychiatric Medications at Admission: What Happens to Them

People entering treatment are sometimes afraid that their antidepressant or other psychiatric medication will be stopped. In general, medications that were prescribed and taken as directed are reviewed by the medical team and continued unless there is a clinical reason to change them. Do not stop an antidepressant, mood stabilizer or antipsychotic on your own before admission; abrupt discontinuation of some of these medications can cause significant withdrawal effects or a return of symptoms.

Benzodiazepines are a separate case. Stopping benzodiazepines suddenly, like stopping alcohol after heavy daily use, can cause seizures and can be life-threatening. Withdrawal from either must be medically supervised. Tell admissions the exact dose and how long you have been taking it so the medical team can plan a safe taper.

What to Tell Admissions Before You Arrive

Here is a step you can take today: before your admissions call, write down and bring the following, ideally on one page:

  1. Every current medication: Name, dose, prescriber and the date you last took it, including anything taken irregularly.
  2. Past diagnoses: Any mental health diagnosis you have been given, by whom, and roughly when.
  3. Sober-period history: Whether depression, anxiety or panic were present during any stretch of 30 days or more without alcohol or drugs.
  4. Past hospitalizations or crisis care: Including any psychiatric holds or emergency visits.
  5. Current safety concerns: Any recent thoughts of suicide or self-harm, even if they have passed.

Then ask admissions three specific questions: “Who on your team does the psychiatric evaluation, and when in the stay does it happen?” “How often is the diagnosis revisited after withdrawal?” and “How will mental health care continue after discharge?” A program that offers integrated mental health treatment should be able to answer all three without hesitation.

If you would like to talk this through before admission, call our team at (877) 328-1968.

How Co-Occurring Care Fits Into Residential Treatment

In residential treatment, integrated care usually means the same team is watching both the substance use and the mental health picture day to day. Therapy groups address cravings and relapse prevention alongside mood regulation, sleep, and anxiety skills. Individual sessions give room to work on trauma or grief once the person is stable enough. The psychiatric provider adjusts medications based on how symptoms evolve rather than on a single snapshot from intake.

Insurance coverage for co-occurring care varies by plan. If cost is a concern, you can verify your insurance benefits before admission so there are no surprises about psychiatric services.

After Discharge: Keeping the Diagnosis Accurate

A diagnosis made in residential treatment is a working diagnosis. It should travel with the person to their outpatient therapist and prescriber, who can confirm or revise it as sobriety continues. Ask for a written summary of the psychiatric evaluation and current medications at discharge, and bring it to the first outpatient appointment. The SAMHSA National Helpline can help locate continuing care if you are moving to a different area.

When Symptoms Are an Emergency

If you or someone you love is thinking about suicide or is in immediate danger, call or text 988 to reach the 988 Suicide and Crisis Lifeline, or call 911. Do not wait for an admissions appointment.

For questions about residential treatment for co-occurring substance use and mental health conditions in Northern California, call Bodhi Addiction Treatment at (877) 328-1968.

This article is for educational purposes only and is not a substitute for professional medical or psychiatric advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Never stop or change a prescribed medication without medical guidance.

Capitola Beach — Bodhi Addiction Treatment & Wellness

Most people who think about leaving residential treatment early do it in the first week, often between day three and day seven. Withdrawal is easing, sleep is still broken, the novelty has worn off, and a voice says, “I’m fine now. I can do the rest at home.” Families get the phone call that starts with “Come pick me up.”

This guide explains what actually happens when someone leaves residential treatment against medical advice (AMA), why the first 24 hours afterward carry real medical risk, and the specific things to ask for before walking out the door. It is written from the admissions and clinical side of residential care in Northern California, where these conversations happen every week.

What “Against Medical Advice” Means in Residential Treatment

Leaving against medical advice means a person ends their stay before the treatment team recommends discharge. For an adult who admitted voluntarily, residential treatment is not a locked setting, and the program generally cannot hold someone who chooses to leave. What staff can do is slow the moment down, make sure the person is medically safe to go, and send them out with a plan instead of nothing.

In practice, an AMA discharge usually involves a conversation with a counselor or clinical lead, a check with medical staff about current withdrawal status and medications, and a form acknowledging that discharge is against the team’s recommendation. Signing that form does not erase the person’s record or bar them from coming back. It documents that the risks were explained.

Why People Leave Early: The Common Triggers

The reasons people give for leaving are usually not the real reasons. In residential work, the same handful of pressures show up again and again:

  • Post-acute withdrawal discomfort: Poor sleep, irritability, and low mood can linger for days or weeks after acute withdrawal ends, and they feel like proof that treatment “isn’t working.”
  • Cravings that peak without warning: A craving can arrive as a sudden, urgent certainty that leaving is the only reasonable choice, then fade within hours if the person stays put.
  • Outside pressure: A partner, employer, landlord, or court date creates a deadline that feels more pressing than the remaining days of care.
  • Conflict on the unit: A disagreement with a peer or staff member turns into “this place isn’t right for me.”
  • Feeling better too fast: Once the fog lifts, it is easy to mistake physical stabilization for recovery and conclude the job is done.

Naming the trigger matters, because most of them have a fix that does not require leaving: a medication adjustment, a room change, a call with the employer, a family session.

The Medical Risks in the First 24 Hours After Leaving

Leaving early is not only a setback in progress. Depending on the substance, it can be physically dangerous.

Alcohol and benzodiazepines: If someone leaves while still in withdrawal from alcohol or partway through a benzodiazepine taper, they can develop seizures and other serious complications. Withdrawal from either should only happen under medical supervision. Stopping a taper abruptly, or drinking to “take the edge off” after leaving, can make things worse. If a person who has left shows confusion, shaking, hallucinations, or a seizure, call 911.

Opioids and lost tolerance: After even a short period without opioids, tolerance drops. Returning to a previous amount, especially in a drug supply that may contain fentanyl, can cause an overdose. According to the National Institute on Drug Abuse (NIDA), naloxone can rapidly reverse an opioid overdose and quickly restore normal breathing, and it is available as a prepackaged nasal spray that requires no assembly.

Interrupted medications: People leaving mid-stay may be partway through starting buprenorphine, a psychiatric medication, or a medication for alcohol use disorder. Leaving without a prescription or a follow-up appointment can create a gap at the worst possible time.

Before You Walk Out: Five Things to Ask For Today

If you or someone you love has decided to leave residential treatment early, these five requests take less than an hour and can be the difference between a rough week and an emergency. Ask the staff, in this order:

  1. A medical check before you go. Ask the nurse or medical provider, “Am I medically safe to leave today, and what symptoms should send me to the ER?” Write the answer down.
  2. Your current medication list and prescriptions. Ask for printed copies of every medication, dose, and the next scheduled dose, plus prescriptions or a bridge supply where appropriate.
  3. Naloxone, if opioids are part of the history. Ask for a naloxone kit to take home, and make sure someone in the household knows where it is kept.
  4. A next appointment, not a phone number. Ask staff to book a specific date and time with an outpatient provider, a partial hospitalization program, or an outpatient program before you leave the building.
  5. The readmission question. Ask directly, “If I change my mind in a day or a week, what is the process to come back?” Knowing the door is open makes it easier to walk back through it.

A practical step for families: if your loved one calls asking to be picked up, ask them to wait 30 minutes and talk to their counselor first, then call the program yourself. Many urges to leave pass in that window.

What Families Can Do When the “Come Get Me” Call Comes

That phone call is hard. You want your loved one to be comfortable, and you also know what happened the last time they came home early. A few things help:

  • Stay calm and ask what happened today, rather than arguing about leaving.
  • Tell them you love them and that you support them finishing treatment.
  • Ask whether they have talked with their counselor or the medical team yet.
  • If they leave anyway, focus on safety: naloxone in the house, a follow-up appointment on the calendar, and a clear plan for what you will do if symptoms of withdrawal or overdose appear.

Families can also call our admissions team for guidance on how to handle the conversation, even if the person is in treatment somewhere else. Reach us at (877) 328-1968.

Free Help Is Available at Any Hour

Leaving residential treatment early does not end the option of getting help. SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential treatment referral and information service that operates 24 hours a day, 365 days a year, in English and Spanish, for individuals and families facing mental health or substance use disorders, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). If someone has left treatment and is struggling at 2 a.m., that line is answered.

If someone is in immediate danger or is having thoughts of suicide, call or text 988 or call 911.

Leaving Is Not the End of the Story

An AMA discharge is common, and it is not a moral failure. Many people who leave early come back, sometimes within days, and do well the second time because they understand what they are walking into. What matters most is that the person leaves with a medical check, their medications, naloxone where relevant, and a real appointment, and that everyone knows how to come back.

If you are weighing whether to leave treatment, or trying to help someone who already has, talk to us first. Call (877) 328-1968 to speak with our admissions team about next steps, readmission, or a lower level of care that fits where you are now.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and requires medical supervision. Always talk with a qualified healthcare provider about your specific situation. If you are experiencing a medical emergency, call 911.

Peaceful natural setting representing mindfulness practice in addiction recovery

Almost every admissions call eventually gets to the same question, usually asked a little sheepishly: “Can I smoke there?” or “Can I bring my vape?” It sounds like a small logistics detail next to detox and insurance. In practice, nicotine shapes the first week of residential treatment more than most people expect, and a plan for it, made before admission day, removes one of the most common reasons people feel like leaving early.

This guide covers how nicotine is usually handled in residential drug and alcohol treatment, which medications exist, how nicotine withdrawal overlaps with other withdrawal, and the specific questions to ask admissions before you arrive.

Why Nicotine Belongs in the Treatment Plan

Tobacco and nicotine use are far more common among people with substance use disorders than in the general population, a pattern documented by the National Institute on Drug Abuse (NIDA). For a long time, many programs treated cigarettes as the one habit to leave alone during recovery, on the theory that quitting everything at once was too much. That view has shifted. Federal guidance from SAMHSA encourages behavioral health programs to address tobacco as part of care rather than set it aside, and research summarized by NIDA generally suggests that working on nicotine during addiction treatment does not undermine recovery from other substances and may support it.

That does not mean anyone is required to quit nicotine the day they walk in. It means nicotine is a clinical question that deserves an answer in the admission plan, the same way sleep, medications, and withdrawal do.

The Seven FDA-Approved Quit Medications

The U.S. Food and Drug Administration has approved seven medications to help people quit smoking, according to the Centers for Disease Control and Prevention (CDC): five forms of nicotine replacement (the patch, gum, lozenge, inhaler, and nasal spray) and two non-nicotine prescription pills, varenicline and bupropion. A person entering residential treatment in California can ask admissions which of these seven the program can continue, order, or start on site, and whether a combination such as a patch plus gum or lozenges is used, since pairing a long-acting and a short-acting form is a common clinical approach.

A few practical points about these medications in a residential setting:

  • Nicotine replacement can start on day one. Patches and gum do not require a quit date to be set in advance, which makes them the most common option during the first days of a stay.
  • Varenicline and bupropion take time to build. Both are typically started before a planned quit date rather than on it. The prescribing clinician sets the schedule, so this is worth raising early in a stay rather than the week before discharge.
  • Bupropion needs a medical review. It is not appropriate for everyone, including people with a seizure history or those currently withdrawing from alcohol or sedatives. That decision belongs to the medical team.
  • Insurance and cost vary. Coverage for quit medications differs by plan. When you verify your insurance, it is reasonable to ask whether tobacco cessation medications are covered.

Why Nicotine Withdrawal Gets Confused With Everything Else

One of the most useful things we see in the first week is simply naming what is nicotine. People arrive already dealing with withdrawal from alcohol, opioids, stimulants, or sedatives. If their nicotine intake also drops sharply because smoking is limited to set times and places, a second withdrawal stacks on top of the first, and the two are hard to tell apart from the inside.

The overlap is real. Nicotine withdrawal commonly brings these, often within the first few days of cutting down:

  • Irritability: a short fuse that often gets read as “treatment isn’t working” or “I don’t belong here.”
  • Restlessness and poor concentration: the same complaints people have during early alcohol or stimulant withdrawal, which makes groups feel unbearable.
  • Sleep disruption: already common in early recovery, and nicotine changes can make it worse.
  • Cravings that blur together: an urge for a cigarette and an urge for the primary substance can feel like one undifferentiated “I need something.”

The practical consequence is that someone can decide to leave treatment over discomfort that a nicotine patch would have eased. In our experience, asking “When did you last have nicotine, and how much do you usually use in a day?” is one of the most clarifying questions on intake, and it often changes the plan for the first 72 hours.

An important safety note: nicotine withdrawal is uncomfortable but not medically dangerous. Withdrawal from alcohol or benzodiazepines is different and can cause seizures. If you are stopping alcohol or a benzodiazepine, medical supervision is required. Do not reduce or stop those substances on your own before admission without speaking to a medical provider. Our residential treatment program coordinates withdrawal management with medical staff for exactly this reason.

Smoking, Vaping, and House Rules

Policies differ widely between residential programs in California. Some allow smoking in a designated outdoor area at set times. Some are entirely tobacco-free on the property. Many restrict vapes specifically, because cartridges are easy to refill with substances other than nicotine and are hard for staff to check. None of these policies is wrong, but finding out about them on admission day, without a replacement plan, is how people end up miserable in week one.

Families also notice something worth knowing: smoke breaks become social. In programs that allow them, the smoking area is often where people talk most openly. That is not a reason to keep smoking, but it explains why people resist giving it up in the middle of treatment, and why a plan that respects that reality tends to work better than an ultimatum.

What to Do Before Admission Day

Here is a short check you can run this week if you or a family member is preparing for residential treatment.

  1. Write down your actual daily nicotine use. Cigarettes per day, vape pods per day, or pouches per day, plus how soon after waking you use. These numbers are what the medical team uses to choose a replacement dose.
  2. Ask admissions three specific questions: Is the property tobacco-free, or is smoking allowed in a designated area? Are vapes permitted, and if not, what happens to one I bring? Which nicotine replacement products or quit medications can you provide on day one?
  3. Ask whether nicotine is addressed in the treatment plan. You are not committing to quit by asking. You are making sure someone has thought about it.
  4. Do not stockpile. Bringing cartons or extra vapes usually results in them being held at intake. Bring the information instead.

If you want help working through these questions, call our admissions team at (877) 328-1968. We can tell you how nicotine is handled on site and what medication options are available before you commit to a date.

After Discharge: Keeping Nicotine in the Plan

Whatever someone decides about nicotine during a residential stay, the decision should carry into the discharge plan. If a person started nicotine replacement or a prescription quit medication in treatment, the discharge paperwork should say which product, what dose, and who will continue prescribing it. Gaps in that handoff are common, and a person who runs out of patches in the second week home is facing nicotine withdrawal at the same moment they are adjusting to life outside a structured setting.

Free telephone coaching is available nationally through 1-800-QUIT-NOW, which connects callers to their state quitline, as described by the CDC. Adding that number to the discharge plan costs nothing and gives the person a resource that is available beyond office hours.

A Note From Clinical Practice

As a counselor and interventionist, I have watched nicotine decide more admissions than most people would believe. The person who is ready to stop drinking but cannot picture three weeks without a cigarette will sometimes delay treatment over that one fear. A clear, honest answer about nicotine policy and replacement options, given on the first phone call, removes the fear and keeps the focus where it belongs.

If you are weighing residential treatment for yourself or someone you love, reach out at (877) 328-1968. We will walk you through admissions, insurance, and what the first week will look like, including the nicotine question.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions, including nicotine replacement and prescription quit medications, should be made with a qualified medical provider. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you are in crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911 in an emergency.

Clinical setting where sleep after quitting meth is monitored during residential recovery

When a family calls about methamphetamine or cocaine, one of the first questions is usually some version of “What medication will they put him on?” For opioids or alcohol, there is a real answer. For stimulants, there is not, and that single fact changes how a residential stay should be planned, how long it should run, and what has to be in place on discharge day. This post walks through those planning decisions in the order admissions actually works through them.

The Short Answer: No Medication Exists Yet

According to the National Institute on Drug Abuse (NIDA), there is no FDA-approved medication for methamphetamine use disorder or for any other stimulant use disorder, including cocaine. NIDA reports that stimulant withdrawal symptoms typically peak two to three days after last use and may last about a week, while low mood, anxiety and cravings can continue for several months. Because there is no medication to bridge that gap, residential treatment for stimulant use disorder relies on behavioral treatment, with contingency management the best-studied option, alongside cognitive behavioral therapy, group support and motivational interviewing.

That paragraph is the whole planning problem in miniature. The acute phase is short. The vulnerable phase is long. And the tool that carries people through the long phase with opioids, a daily medication, does not exist here yet.

What We See in the First Week

In our admissions work, the stimulant intake that worries families most is often the quiet one. A person who arrived agitated and talking fast is, by day two or three, sleeping most of the day, eating everything on the tray and saying very little. Families on the phone read that as either “he’s fine now” or “something is wrong.” Usually it is neither. It is the crash phase NIDA describes, and it is the point where people most often decide they no longer need to be here, because the chaos that brought them in has gone quiet.

The second pattern is the one that matters for discharge planning: in our experience, a few weeks in, after sleep and appetite settle, cravings tend to return in a different form, cued by a song, a payday, a particular freeway exit. A plan built only around the first week misses this entirely.

Why Stimulant Plans Look Different

These are the mechanisms our clinical team plans around when a stimulant is the primary substance:

  • No medication bridge: without an FDA-approved medication, nothing pharmacological holds cravings down after discharge, so the behavioral plan has to be stronger and start earlier.
  • Short acute phase, long tail: withdrawal peaks within days, but NIDA notes mood and craving symptoms can last months, which is why length of stay should not be set by how someone looks on day seven.
  • Misleading recovery of energy: once sleep normalizes, people often feel better than they have in years, and that feeling is frequently mistaken for being finished with treatment.
  • Cue-driven cravings: stimulant cravings are strongly tied to people, places and routines, so the relapse-prevention plan has to name specific cues rather than general “triggers.”
  • Hidden polysubstance use: many people who use stimulants also use alcohol, benzodiazepines or opioids to come down, and that second substance can carry the greater medical risk.

The Safety Piece Admissions Must Hear

Stimulant withdrawal itself is rarely medically dangerous in the way alcohol withdrawal is, but the substances people use alongside stimulants can be. Alcohol and benzodiazepine withdrawal carry a risk of seizures and require medical supervision. If your loved one drinks heavily or takes Xanax, Klonopin, Valium or similar medications to sleep after using, tell admissions on the first call. That information changes whether medical detox is needed before residential care.

NIDA also notes that methamphetamine, alone or combined with fentanyl, contributes to the overdose crisis. Anyone who uses stimulants from an unregulated supply should have naloxone available, and anyone returning home after reduced use faces changed tolerance.

The crash phase can bring heavy depression. If someone talks about suicide, call or text 988. If there is chest pain, a seizure, severe confusion or psychosis, call 911.

Questions to Ask on the Admissions Call

Here is something you can do today. Before you commit to any program, ask these five questions and write down the answers:

  1. “How do you treat stimulant use disorder specifically?” Listen for named approaches such as contingency management or cognitive behavioral therapy, not just “individual and group therapy.”
  2. “How is length of stay decided?” A good answer references clinical reassessment over time, not a fixed number of days that happens to match an insurance authorization.
  3. “What happens if they want to leave on day three?” Ask what staff actually do, and whether family will be contacted if the person has signed consent.
  4. “Do you screen for alcohol and benzodiazepine use at intake?” The answer should be yes, with a clear path to medical detox if needed.
  5. “What does the step-down plan look like?” Ask whether they arrange outpatient treatment or intensive outpatient care before discharge, with a first appointment date already set.

If you want to talk through these with someone before calling anywhere else, our team is available at (877) 328-1968.

How Length of Stay Gets Decided

For stimulant use disorder, length of stay in residential treatment is driven by clinical criteria, typically the ASAM dimensions, rather than by withdrawal severity, because withdrawal is usually over within the first week. What clinicians are actually watching after that is relapse risk, the home environment and whether the person can name and manage their own cues.

Insurance authorizations are often issued in short blocks and reviewed. That is normal. What families should know is that a utilization review asking “why is this person still here if withdrawal is over?” is answered with documentation about relapse risk and recovery environment, not withdrawal. If you are unsure what your plan covers, you can verify insurance benefits before admission so there are no surprises at the first review.

Contingency Management: What It Is and How to Ask

Contingency management offers small, tangible incentives, such as vouchers or gift cards, for verified progress such as negative drug tests or attendance. NIDA describes it as the best-studied behavioral treatment for methamphetamine use disorder and the one most associated with treatment success. It can feel counterintuitive to families. It works in part because stimulants hijack the brain’s reward system, and small, immediate, predictable rewards help rebuild that system around something other than the drug.

Availability varies by program and payer. Ask directly whether it is offered during residential care, after discharge, or through a referral, and who pays for the incentives.

Discharge Without a Prescription

When someone leaves residential treatment for opioid use disorder, a medication often travels with them. With stimulants, the discharge plan has to carry that weight instead. Before discharge day, confirm in writing:

  • The date and time of the first outpatient or IOP appointment
  • A named list of personal cues and the plan for each
  • Whether mental health follow-up is scheduled for mood symptoms that may persist
  • Where naloxone is kept at home
  • Who the person will call in the first 72 hours if cravings spike

SAMHSA’s National Helpline, 1-800-662-HELP (4357), is a free, confidential, 24/7, 365-day-a-year referral service in English and Spanish, and it is a useful backup number to keep on the fridge.

A Note From the Clinical Side

The families who do best with stimulant treatment are usually not the ones who found the perfect program. They are the ones who stopped measuring progress by how their loved one looked in week one and started asking what the plan was for week eight. That shift alone changes the conversation with any treatment team. Learn more about Jonathan Beazley and the clinical approach at Bodhi.

If someone you love is using methamphetamine or cocaine and you are trying to figure out next steps, call us at (877) 328-1968. We can help you sort out level of care, insurance and timing, even if Bodhi turns out not to be the right fit.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Alcohol and benzodiazepine withdrawal can cause seizures and require medical supervision. If you or someone you know is in crisis, call or text 988, or call 911 in an emergency.

Clinician reviewing the cocaine withdrawal timeline with a client in residential detox

For many people finishing residential treatment, the hardest question is not whether to keep going in recovery. It is where to sleep on the night of discharge. Going straight back to the same apartment, the same roommates, and the same routines is a real risk, and sober living is often the answer families reach for. But “sober living” covers a wide range of homes in California, from carefully run residences with house managers and written standards to a rented house with a list of rules taped to the fridge. This guide explains how sober living is regulated here, what the support levels mean, and the specific things to confirm before anyone signs a lease or pays a deposit.

What Sober Living Is, and What It Is Not

In California, a sober living home that provides no treatment services generally does not need a license from the Department of Health Care Services (DHCS), the state agency that licenses residential addiction treatment facilities. That means the protections that come with a licensed residential treatment program, such as required staffing, clinical oversight, and state inspection, do not automatically apply to a sober living home. Families can check quality through voluntary standards instead: the National Alliance for Recovery Residences (NARR) defines four levels of recovery residence support, from Level I (peer-run, no paid staff) to Level IV (a clinical setting that is usually a licensed program). Asking which level a home operates at, and whether it is certified by a NARR affiliate, is the fastest way to know what a given house actually offers.

Sober living is housing with structure. It is not treatment. A good home expects residents to be engaged in treatment somewhere else, usually an outpatient or intensive outpatient program, plus mutual-support meetings, work, or school. If a home describes itself as providing therapy, medication management, or detox without a DHCS license, that is a question worth asking directly.

Why the Weeks After Residential Treatment Carry Extra Risk

The National Institute on Drug Abuse describes addiction as a chronic condition and notes that remaining in treatment for an adequate period is important to good outcomes (see NIDA’s Principles of Drug Addiction Treatment). The step down from 24-hour care is where that continuity is easiest to lose. Several things change on the same day:

  • Structure drops away: a residential schedule fills nearly every hour, and discharge can leave whole afternoons empty.
  • Tolerance is lower: after a period without opioids, a return to a previous dose can cause an overdose, which is why naloxone should go home with anyone who has used opioids.
  • Old cues return: the same streets, contacts, and stressors that were present before treatment are there waiting.
  • Accountability thins out: no one is checking in at breakfast, and early warning signs can go unnoticed for days.

A sober living home is one way to keep some of that structure in place while a person rebuilds work, relationships, and outpatient care.

What We See in Placement Work

At Bodhi, our work is matching people with treatment programs and the housing that follows them. A few patterns come up again and again, and none of them appear on a home’s website.

Medication policies vary more than families expect. Some homes do not accept residents who take buprenorphine, methadone, or certain psychiatric medications, even when those medications were prescribed during treatment. Medications for opioid use disorder are an evidence-based standard of care, and a person should not have to choose between their prescription and their housing. We confirm the policy in writing before a referral, every time.

The bed is often the bottleneck, not the money. Well-run homes near the Bay Area and Santa Cruz County can have waiting lists. When discharge is set but housing is not, people end up going “home for a few days” that turn into weeks. The housing search should start in the second or third week of a residential stay, not the last day.

“Zero tolerance” means different things. In some homes a single positive test means immediate eviction with nowhere to go that night. In others, a return to use triggers a meeting, a safety plan, and a referral back to a higher level of care. Families should know which kind of house they are choosing before anything goes wrong.

Seven Questions to Ask Before Move-In

Bring this list to the tour or the phone call. Ask the house manager to answer in writing, by email or text, so there is a record.

  1. What NARR level do you operate at, and are you certified by a NARR affiliate? Ask for the certifying organization and the date the certification was last renewed.
  2. What is your policy on prescribed medications, including buprenorphine, methadone, naltrexone, and psychiatric medications? How are they stored?
  3. What happens after a return to use? Is there a written relapse policy, and where does the resident go if they must leave?
  4. How often is drug and alcohol testing done, and who pays for it?
  5. What are the total move-in costs? Ask for the deposit, the first payment, weekly or monthly rent, and any program fees as separate line items.
  6. Is there an on-site house manager, and what hours are they present?
  7. What outside participation is required? Outpatient treatment, meetings, employment, curfew, and visitor rules should all be spelled out.

If a home cannot or will not answer these questions, that is useful information too. You can also call our team at (877) 328-1968 and we will walk through the answers with you.

Safety Rules That Apply Whatever the Housing

Sober living homes are not medical settings. If someone returns to heavy drinking or to regular benzodiazepine use and then stops suddenly, withdrawal can cause seizures and can be life-threatening. That person needs medically supervised withdrawal management, not a night of rest at the house. The same is true for anyone showing confusion, hallucinations, a high fever, or severe agitation after stopping a substance. Call 911 in an emergency.

Anyone who has used opioids should keep naloxone in their room and make sure housemates know where it is. Families can find treatment and support options through the SAMHSA National Helpline, which is free, confidential, and available 24 hours a day at 1-800-662-4357. If someone is in emotional crisis or thinking about suicide, call or text 988.

How Sober Living Fits the Discharge Plan

Sober living works best as one piece of a written continuing care plan, not a standalone solution. The American Society of Addiction Medicine’s ASAM Criteria describe care as a continuum, with people moving between levels of intensity as their needs change. In practice, a solid plan names all of the following before discharge day:

  • The sober living address and move-in date
  • The outpatient or intensive outpatient program, with a first appointment date already booked
  • The prescriber who will continue any medications, and the date of the first refill
  • A primary support person, and what they should do if they notice warning signs
  • A clear “if things go wrong” step, such as who to call to return to a higher level of care

One thing you can do today: if a loved one is currently in residential treatment, ask their case manager at the next family call, “Which sober living homes are you considering, and what is each one’s medication and relapse policy?” If the answer is that housing has not been discussed yet, ask to put it on the agenda this week.

Getting Help Choosing the Right Next Step

Choosing housing after treatment can feel like one more decision on top of a dozen others. You do not have to sort through it alone. Our treatment consultants help Northern California families compare residential programs, outpatient options, and recovery residences, and we check the details that matter before a referral is made. Call (877) 328-1968 to talk through your situation.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Sober living policies and California regulations can change, so confirm current details directly with the home and the relevant agency. If you or someone you love is in immediate danger, call 911. For a mental health crisis, call or text 988.

Prescription bottle with pills on a counter — residential rehab for chronic pain and opioid use disorder

When someone calls our admissions line about alcohol or opioids, a benzodiazepine prescription often comes up almost as an afterthought: “I also take Xanax for sleep,” or “My doctor has had me on clonazepam for years.” That detail changes the admission plan more than almost anything else on the intake form. Benzodiazepines cannot be stopped the way many people expect, and the schedule for coming off them is set by clinical guidance, not by how long a residential stay happens to last.

This post walks through how a benzodiazepine taper is actually planned in residential treatment, what the published guidance says about pace, and what you should confirm with a program before you arrive.

Why Benzodiazepines Are Handled Differently at Admission

Benzodiazepines, including alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium), act on the brain’s GABA system. With daily use over weeks or months, the brain adapts. Remove the medication suddenly and that adaptation is left unopposed.

Safety first: stopping a benzodiazepine abruptly after regular use can cause withdrawal seizures, which can be life-threatening. The same is true of alcohol. Anyone who has been using benzodiazepines or alcohol daily should not stop on their own, cut down sharply before a bed opens, or “detox at home” without medical supervision. If you are in that situation now, call us at (877) 328-1968 before changing anything.

The mechanism matters because it explains why programs ask so many questions on the first call. In our admissions work, the families who are most surprised are those whose loved one was prescribed the medication legitimately. Dependence is a physical adaptation, and it can develop whether the prescription was followed exactly or not. The National Institute on Drug Abuse describes this distinction between physical dependence and addiction in its overview of prescription medicine misuse.

What the Published Guidance Says About Taper Pace

In 2025, the American Society of Addiction Medicine and a group of partner medical societies released a joint clinical practice guideline on benzodiazepine tapering. It is the reference point most clinicians now use, and it is the document worth asking a program about by name.

A benzodiazepine taper for someone with long-term daily use is usually measured in weeks to months, not days. The joint clinical practice guideline on benzodiazepine tapering, published in 2025 by the American Society of Addiction Medicine and partner medical societies, describes a typical starting pace of dose reductions of about 5 to 10 percent every 2 to 4 weeks, and generally advises against reductions larger than 25 percent in any 2-week period. That means a person entering a 30- to 45-day residential program on a daily benzodiazepine will often still be tapering at discharge, and the discharge plan needs a named prescriber to continue the schedule.

Pace is individualized. The guideline describes adjusting speed based on how the person tolerates each step, and pausing when symptoms are significant. Some people move faster under close supervision; some need much longer. You can read the guideline summary through ASAM’s clinical guidelines page.

The U.S. Food and Drug Administration added a boxed warning to all benzodiazepines in 2020 covering misuse, dependence, and withdrawal reactions, including the risk of abrupt discontinuation. That warning is one reason prescribers have become more cautious about both starting and stopping these medications quickly.

What Drives the Taper Schedule

When our clinical team builds a taper plan, these are the factors that shape it:

  • Duration of use: months or years of daily use generally call for a slower taper than a few weeks of use.
  • Dose and drug: short-acting drugs like alprazolam can produce sharper swings between doses than longer-acting ones, which is why some prescribers convert to a longer-acting benzodiazepine before reducing.
  • Alcohol or other sedatives: combined use of alcohol and benzodiazepines raises withdrawal risk and requires more intensive medical monitoring.
  • Seizure history: any prior withdrawal seizure moves the plan toward a slower, more closely supervised schedule.
  • Co-occurring anxiety or insomnia: the original reason for the prescription does not go away during a taper, so it needs its own treatment plan, often therapy-based.
  • Opioid use or medication for opioid use disorder: the combination of opioids and benzodiazepines increases overdose risk, and coordination between prescribers is essential. The CDC addresses this risk in its overdose prevention resources.

What the First Weeks Actually Look Like

People expect withdrawal to feel like a single hard week. With a properly paced taper, it is usually quieter and longer than that. In the early reductions, clients commonly describe rebound anxiety, lighter or broken sleep, irritability, and a sense of being “on edge” in the evening. Some notice sensitivity to light or sound. Families on visiting days often say their loved one seems more anxious than before treatment, and they worry the program is not working.

That is often what a taper feels like when it is working. The nervous system is readjusting step by step, and each reduction is followed by a period of settling before the next one. This is where residential care earns its place: nursing staff can watch vital signs and symptoms daily, the prescriber can hold a step if needed, and the person is learning non-medication tools for anxiety and sleep in real time, during the exact hours when the old medication used to do that job.

The inconvenient truth from the admissions side is that the hardest conversation is often not about the drug at all. It is telling someone that their benzodiazepine taper will likely continue after they leave our residential program, and that the most important document they take home may be the outpatient prescriber’s appointment, not the discharge summary.

Five Things to Confirm Before Admission

If you or a family member takes a benzodiazepine daily, ask these questions on the admissions call. Write down the answers.

  1. Who manages the taper? Ask for the role of the person who will set and adjust the schedule, such as a physician or psychiatric nurse practitioner, and how often they see clients.
  2. Is the program medically equipped for sedative withdrawal? Ask what level of medical monitoring is available on site and what happens if symptoms escalate. Our residential treatment page explains how care is structured.
  3. Bring every prescription bottle. Bring the actual bottles, with current labels, plus the name and phone number of the prescribing doctor. Today, check the label: write down the drug name, dose, and how many tablets are taken each day. That single list speeds up the medical assessment.
  4. What happens to the taper at discharge? Ask whether the program coordinates a hand-off to an outpatient prescriber and whether that appointment is booked before you leave.
  5. What does insurance cover? Medically monitored withdrawal management may be billed differently than residential care. You can start with a confidential insurance verification.

Do not reduce your dose in the days before admission to “get a head start.” A sudden cut while you wait for a bed is exactly the kind of change that carries seizure risk.

How We Approach This at Bodhi

At Bodhi Addiction Treatment in Northern California, benzodiazepine tapers are planned individually, with medical oversight and a discharge plan that names who continues the schedule. Our clinical approach reflects the practice experience of our founder, Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i, and our team’s work with clients managing both substance use and the anxiety that often came before it.

If you are unsure whether a current prescription affects your admission, the fastest step is to ask. Call (877) 328-1968 and have the prescription label in front of you. If you need help finding treatment anywhere in the country, SAMHSA’s National Helpline is free, confidential, and available 24 hours a day at 1-800-662-4357. If you are in crisis or thinking about harming yourself, call or text 988.

This article is for educational purposes only and is not medical advice. Do not start, stop, or change the dose of any medication without guidance from a qualified healthcare provider. Benzodiazepine and alcohol withdrawal can be dangerous and require medical supervision. If you are experiencing a medical emergency, call 911.

alcohol detox retreat

Most families find a residential program the same way: a late-night search, a polished website, and a phone call to an admissions line that answers on the first ring. Within an hour, someone is offering a bed for tomorrow. That speed can feel like relief. It can also be the moment a family commits to a program it has not checked at all.

At Bodhi, our work is placing people into residential, PHP, and outpatient programs, which means we vet programs for a living. This guide lays out the checks we run, in the order we run them, so you can do the same before anyone packs a bag. If you would rather have us run them with you, call (877) 328-1968.

The Short Version: What to Verify Before Admission

Before committing to a residential drug or alcohol program in California, a family should confirm five things in writing: that the facility holds a current residential license from the California Department of Health Care Services (DHCS) for the address where the person will actually sleep; which ASAM level of care the program delivers, such as 3.5 or 3.7; who manages withdrawal and what happens if symptoms escalate overnight; how the program bills your specific insurance plan; and what the discharge plan will include. If a program cannot answer all five clearly on one phone call, keep looking. SAMHSA’s National Helpline, 1-800-662-4357, is free, confidential, and open 24 hours a day, 365 days a year, and can point you toward licensed options if you are starting from nothing.

Step One: Confirm the License Matches the Address

In California, residential addiction treatment programs are licensed by DHCS, and the license is tied to a specific facility address. A program’s website may list one headquarters while clients actually sleep in a separate house across town. What you want to know is whether that house is licensed for residential treatment.

Ask the admissions coordinator for the facility’s DHCS license number and the street address it covers, then check it against the state’s public licensed-facility listing. This takes about ten minutes. In our placement work, the gap we run into most is not an unlicensed program, but a licensed program whose overflow beds sit at an address that is not on the license. That is a question worth asking directly: “Will my family member sleep at the licensed address for the entire stay?”

Accreditation from bodies such as The Joint Commission or CARF is a useful additional signal, but it does not replace the state license.

Step Two: Ask Which ASAM Level of Care They Provide

“Residential” covers a wide range. The American Society of Addiction Medicine (ASAM) Criteria divide residential care into levels with different staffing and medical capability. In broad terms, Level 3.1 is a lower-intensity, clinically managed setting; Level 3.5 is a clinically managed, high-intensity program for people who need a structured 24-hour environment; and Level 3.7 adds medical monitoring, with nursing and physician involvement available around the clock.

Why this matters in practice: a person who needs 3.7-level medical monitoring placed into a 3.1 setting is a safety problem, and a person placed far above their needs may face insurance pushback. Our residential treatment overview explains how these levels fit with step-down care. If you are unsure which level fits, a level-of-care assessment should come before the admission, not after.

Step Three: Pin Down Who Handles Withdrawal

This is the question we press hardest, because it is where the consequences are most serious. Alcohol and benzodiazepine withdrawal can cause seizures and can be life-threatening, and they require medical supervision. Alcohol withdrawal symptoms commonly begin within about 6 to 24 hours after the last drink, which means the first night at a facility can be the riskiest one.

Ask these questions word for word:

  • “Is withdrawal management done on-site, and is the facility licensed or certified for that service?”
  • “Is there a nurse awake in the building overnight?”
  • “Who decides when someone needs to be transferred to a hospital, and how fast does that happen?”
  • “If detox happens somewhere else first, who coordinates the handoff and on what day?”

A strong program answers these without hesitation. A weak answer sounds like “our staff is trained to handle it” without naming who is on shift at 2 a.m.

Step Four: Get the Insurance Answer in Writing

“We take your insurance” is not the same as “we are in-network with your specific plan and have verified your residential benefit.” Ask for the verification of benefits in writing: deductible remaining, out-of-pocket maximum, whether prior authorization is required, and how many days are authorized at the start. Initial authorizations are often shorter than families expect and are reviewed as treatment goes on.

You can run a check through our insurance verification page before choosing a program, which gives you a baseline to compare against what admissions tells you.

Warning Signs We See in Placement Work

Over years of placing California families, a handful of patterns have reliably predicted a poor experience. None of them proves wrongdoing on its own, but each one is a reason to slow down.

  • Free travel or cash incentives: California law (SB 1228, signed in 2018) prohibits licensed treatment providers from paying or receiving anything of value for patient referrals, so offers of free flights or gift cards to enroll are a serious red flag.
  • Pressure to decide within the hour: urgency is real when someone is in crisis, but a legitimate program will still give you the license number and a written benefits summary before you commit.
  • Vague clinical staffing: if no one can tell you the credentials of the therapists or the name of the medical director, the clinical program may be thinner than the website suggests.
  • Silence about discharge: programs that never mention aftercare tend to treat the stay as the whole plan, when recovery planning should begin early in the stay.
  • Refusal to involve family at all: privacy rules limit what a program can share without consent, but a good program will explain how consent works and how family sessions are scheduled.

What Families Actually Notice in the First Week

Families often tell us the first sign a program is right is boring logistics working smoothly: the call back that comes when promised, the medication list that gets reconciled on day one, the counselor who learns the person’s name before the intake paperwork is finished. The first sign a program is wrong is usually the opposite: calls that go unanswered, a different story each time about when the doctor will see your family member, or confusion about who is responsible for what.

For the person in treatment, week one is often physically and emotionally rough regardless of program quality. Sleep is broken, irritability runs high, and the urge to leave can be strong. That is expected. What should not be happening is uncertainty about basic safety, medication, or whether anyone is paying attention.

Why Evidence-Based Care Is the Baseline

The National Institute on Drug Abuse’s principles of effective treatment emphasize that no single treatment is right for everyone, that staying in treatment long enough matters, and that care should address the whole person, including co-occurring mental health conditions. Ask any program how it handles depression, anxiety, or trauma alongside substance use, and whether it supports medications for alcohol or opioid use disorder when clinically appropriate. A program that dismisses FDA-approved medications outright is narrowing your options before an assessment has even been done.

For alcohol use disorder specifically, the NIAAA Alcohol Treatment Navigator offers free guidance on questions to ask providers, which pairs well with the steps above. SAMHSA’s National Helpline is another neutral starting point.

Do This Today: The Ten-Minute Phone Check

Before you agree to an admission date, call the program and ask for three things in a single call: the DHCS license number and the address it covers, the ASAM level of care they will provide, and the name or role of the person who manages withdrawal overnight. Write down the answers and who gave them. Then compare the license against the state listing. If any of the three is missing, or changes on a second call, treat it as a no.

If you want a second set of eyes, our treatment consulting team can walk through the answers with you and suggest vetted programs that fit the level of care your family member needs. Call (877) 328-1968 to talk it through.

If someone is in immediate danger, call 911. If you or someone you love is in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can be dangerous and should only happen under medical supervision. Always consult a qualified healthcare provider about your specific situation.

Santa Cruz Outpatient Addiction Therapy Program

Most families call us about packing the night before admission. By then the question is rarely “what clothes should I bring?” It is usually “she drank until midnight — is that a problem?” or “he stopped his Xanax on his own so he could arrive clean.” After years of placing Northern California families into residential programs, I can say the suitcase is the easy part. What actually decides how smoothly admission day goes is paperwork, medications, and an honest account of the last drink or dose.

This guide walks through admission day for residential treatment in the order it actually happens, with a checklist you can complete today. If you have not yet confirmed coverage, start with our insurance verification page or call (877) 328-1968 before you pack anything.

Do Not Stop Drinking or Taking Benzodiazepines on Your Own Before Admission

People entering residential treatment for alcohol or benzodiazepine use should not quit abruptly on their own in the days before admission, even to “show up sober.” Alcohol withdrawal symptoms commonly begin within 6 to 24 hours of the last drink, which means a person who stops the night before can be entering the most unpredictable stretch of withdrawal while sitting in a car on the way to intake. Alcohol and benzodiazepine withdrawal can cause seizures and, in severe cases, delirium; both require medical supervision. The safer approach is to keep use steady and unchanged as instructed by the admissions team, then report the exact time and amount of the last use at intake so the medical staff can plan detox from accurate information.

That paragraph is the single most important thing in this article. The American Society of Addiction Medicine’s alcohol withdrawal management guideline treats withdrawal as a medical process to be assessed and monitored, not an endurance test. In practice, the families I work with who arrive with a clear, honest timeline get settled faster, because the nursing team is not guessing.

If you or someone you love is already in withdrawal and shows confusion, hallucinations, a seizure, or a racing heart with heavy sweating, call 911. Do not wait for the admission date.

Why Admission Day Goes Wrong: The Four Usual Causes

Most delayed or rocky admissions trace back to a short list of avoidable problems:

  • Missing medication information: Without pharmacy-labeled bottles or a printed list, the medical team may not be able to continue a prescription until it is confirmed with the prescriber.
  • An inaccurate use history: Understating the amount or recency of use is common and human, but it can lead to withdrawal being under-treated in the first 48 hours.
  • Unresolved insurance questions: A benefits check that was never completed, or an authorization still pending, can hold up admission paperwork on arrival.
  • Prohibited items in the bag: Anything containing alcohol, unapproved supplements, or sealed items that cannot be inspected adds time to the intake search and sometimes a difficult conversation.

None of these are character problems. They are logistics, and every one of them can be handled the day before.

The Documents Folder: What to Bring

Put these in a single folder or large envelope, not scattered through luggage:

  • A government-issued photo ID.
  • Your insurance card (front and back copies are helpful too), plus the name of the policyholder if it is not you.
  • A printed list of every medication, the dose, the time you take it, and the prescriber’s name and phone number.
  • Contact information for anyone the program may speak with once you sign a release: a spouse, a parent, a therapist, a primary care doctor.
  • Any legal paperwork with dates attached, such as a court date, probation contact, or a medical leave form your employer needs completed.
  • A small amount of cash or a debit card for incidentals, if the program allows it.

Releases of information matter more than people expect. Federal confidentiality rules for substance use treatment records are strict, so staff generally cannot confirm to a family member that you have even arrived unless you have signed a release. Decide before admission who you want looped in.

The Medication Bag

Bring every current prescription in its original pharmacy-labeled bottle, including medications for blood pressure, diabetes, thyroid, mental health, and anything prescribed for sleep or anxiety. Do not consolidate pills into a pill organizer before arrival; staff need to see the label to verify it. The program’s medical team will review each one, may adjust some during detox, and will typically hold and dispense them. This includes over-the-counter products and supplements, which many programs restrict or need to approve.

If you take buprenorphine, methadone, or another medication for opioid use disorder, tell the admissions team before the admission date, not on arrival. The National Institute on Drug Abuse describes these medications as an evidence-based part of treatment, and a good residential program should have a plan to continue them rather than interrupt them.

The Suitcase: Clothing and Personal Items

Plan for about a week of comfortable clothing, since most residential programs have laundry access. Northern California weather swings a lot between morning and afternoon, especially near the coast, so layers work better than one heavy coat.

  • Comfortable daywear, sleepwear, and closed-toe shoes plus a pair of sneakers for walks or exercise.
  • A light jacket or sweatshirt and a warmer layer for evenings.
  • Toiletries that are alcohol-free and preferably new and sealed (many mouthwashes, hand sanitizers, and some hair products contain alcohol and are commonly restricted).
  • A notebook and pen, a few photos of people you love, and a book.
  • Reading glasses, a CPAP machine, hearing aid batteries, or any medical device you use daily.

Every program has its own contraband list, and they differ. Ask admissions to email you theirs, and pack against it line by line.

What to Leave at Home

Leave valuables, expensive jewelry, large amounts of cash, weapons of any kind, and anything containing alcohol. Vapes, energy drinks, and outside food are handled differently by different programs, so check the list rather than assume. On phones and laptops: many residential programs limit device use, especially during the first days, and some hold them entirely during detox. Before you leave, set up an out-of-office message, give one trusted person access to pay any bills that will come due, and write down the few phone numbers you will actually want.

What Happens in the First Few Hours

Admission day usually follows a predictable sequence: paperwork and consents, a search of belongings, a nursing assessment that includes vital signs and a substance use history, and often a drug screen. A physician or nurse practitioner typically reviews medications and decides whether withdrawal management is needed. Then comes a room assignment and a meal, and people are often surprised at how much of the first day is simply rest.

From the families I talk to afterward, the moment that sticks is rarely the search or the forms. It is the relief of not having to hold the plan together alone anymore. That relief is part of why the residential level of care works for people who have been unable to stop on their own.

Your Admission-Eve Checklist: Do These Five Things Today

  1. Call the admissions team and ask three direct questions: What should the last drink or dose look like before arrival? Can I have your contraband list in writing? Is my insurance authorization complete?
  2. Write down, on paper, the exact substances you use, the typical daily amount, and the time of your most recent use. Update it the morning of admission.
  3. Gather every prescription bottle into one bag and print a medication list with prescriber phone numbers.
  4. Decide who you will sign releases for, and write their names and numbers on a single card.
  5. Arrange a ride. Do not plan to drive yourself, particularly if you are drinking or may be entering withdrawal.

If you want help walking through this list for a specific program, our team does this every week. Call (877) 328-1968 and we can go through it with you, or read more about how we work on Jonathan Beazley’s profile. If you are not yet connected to a program, the SAMHSA National Helpline (1-800-662-4357) is free, confidential, and answers 24 hours a day, 365 days a year. For guidance specific to alcohol, the National Institute on Alcohol Abuse and Alcoholism is a reliable place to start.

If you are in crisis or thinking about harming yourself, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Withdrawal from alcohol and benzodiazepines can be dangerous and requires medical supervision. Always follow the instructions of your treatment program and a qualified medical provider. Program policies on medications, devices, and personal items vary.

Sunlit running trail through nature, representing the role of movement and exercise in early addiction recovery

Most people finishing residential treatment for alcohol use disorder leave with a discharge plan full of meetings, therapy appointments, and sober living options. Far fewer leave with a prescription. That gap is one of the most avoidable problems we see at discharge, and it usually comes down to logistics rather than clinical judgment: nobody started the medication early enough, the pharmacy fill was never confirmed, or the injectable was not authorized before the person walked out the door.

This guide covers what the approved medications are, how a residential program decides which one fits, and the practical steps that determine whether a medication plan actually survives the first week at home. If you are weighing treatment for yourself or someone you love, you can reach our admissions team at (877) 328-1968.

The Three Approved Medications for Alcohol Use Disorder

Three medications are currently approved in the United States to treat alcohol use disorder: naltrexone, acamprosate, and disulfiram, according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA). None of the three is addictive. Naltrexone comes as a daily pill or a long-acting injection and reduces the urge to drink; acamprosate is a pill that eases the uncomfortable symptoms some people feel during early abstinence; and disulfiram is a pill that causes an unpleasant physical reaction if alcohol is consumed. Each can be used on its own or alongside counseling, and the right choice depends on liver and kidney function, other medications, and whether the goal is reducing cravings or building a hard deterrent.

A concern we hear almost every week from families is some version of “Isn’t that just swapping one drug for another?” The short answer is no. These medications do not produce a high, do not cause dependence, and are used the way a person might use a daily medication to manage blood pressure or asthma.

How Each Medication Works

Naltrexone blocks the reward signal: it reduces the pleasurable effect of alcohol and, for many people, the intensity of cravings, which makes it easier to stop after a slip rather than continue.

Acamprosate steadies early abstinence: it is thought to help rebalance brain chemistry disrupted by long-term heavy drinking, which can ease the restlessness, poor sleep, and irritability that often drive a return to alcohol in the first months.

Disulfiram creates a deterrent: it interferes with how the body breaks down alcohol, so drinking produces flushing, nausea, a pounding heart, and other symptoms that make alcohol deeply unappealing while the medication is active.

These are not interchangeable. Naltrexone is often a first choice for people whose main struggle is craving. Acamprosate is often favored for people with liver concerns, because it is cleared through the kidneys rather than the liver. Disulfiram tends to work best when someone is highly motivated and has a supportive person who helps with daily dosing. Your prescriber should explain why one is being recommended over the others.

Why Timing in Residential Treatment Matters

None of these medications treats alcohol withdrawal. Alcohol withdrawal can cause seizures and delirium tremens, which can be life-threatening. Stopping heavy, daily drinking requires medical supervision, and no one should try to detox from alcohol at home using any of these medications as a substitute. The same caution applies if benzodiazepines are also involved, because benzodiazepine withdrawal carries its own seizure risk and requires a supervised taper.

Once withdrawal has been medically managed, residential treatment is often the best window to start an AUD medication. In a residential setting, the care team can watch for side effects such as nausea, headache, or fatigue during the first days, adjust the dose, and switch medications if the first choice is not tolerated. That is much harder to do after discharge, when the first sign of trouble may simply be that the person stops taking the pill.

From practice, the single most useful rule is this: start the medication at least several days before discharge, not on discharge day. A person who leaves already taking a medication they have tolerated is far more likely to keep taking it than a person handed a new prescription on the way out.

Safety Checks Before Starting

Each medication has specific safety requirements that the medical team should review with you:

  • Naltrexone and opioids: naltrexone blocks opioids. A person who has recently used any opioid, including prescribed pain medication, can be pushed into sudden, severe withdrawal. The care team needs an accurate history and typically confirms a sufficient opioid-free period before starting it. Naltrexone also means opioid pain medication will not work normally, which matters for anyone facing surgery or dental work.
  • Naltrexone and the liver: prescribers usually check liver function before and during treatment.
  • Acamprosate and the kidneys: because acamprosate is cleared by the kidneys, kidney function affects the dose, and it may not be appropriate for people with severe kidney impairment. It is usually taken several times a day, which is worth planning around.
  • Disulfiram and hidden alcohol: disulfiram should never be given to anyone without their full knowledge and agreement, and never to someone who has been drinking recently. Reactions can be triggered by alcohol in products such as some mouthwashes, cough syrups, sauces, and hand sanitizers, and the effect can last for days after the last dose.

Tell the medical team about every medication and supplement you take, and about any history of liver disease, kidney disease, heart problems, or depression.

The Discharge Logistics That Decide Whether It Works

This is where plans fall apart, and it is almost never a medical failure. In our work coordinating discharges, the most common breakdowns are operational:

Unfilled prescriptions: the prescription was sent, but the pharmacy did not have it in stock, needed a prior authorization, or the person never picked it up.

No follow-up prescriber: the residential physician prescribed a 30-day supply, but no outpatient provider was lined up to continue it, so the medication ended when the bottle ran out.

Injectable timing: the long-acting naltrexone injection often requires insurance authorization and a clinic that stocks and administers it. If this is not arranged before discharge, the next dose can be missed entirely.

Insurance coverage for these medications varies by plan. Our team can check your benefits before admission through our insurance verification page, and our case management staff can help coordinate the outpatient prescriber and pharmacy before you leave.

Five Questions to Ask Before Your Discharge Date

Bring this list to your next meeting with your prescriber or case manager. Write down the answers.

  1. Which AUD medication are you recommending for me, and why that one rather than the other two?
  2. What date will I start it, and how many days will I take it here before I leave?
  3. Has the prescription been sent to my pharmacy, and has someone confirmed it is in stock and covered?
  4. Who is my outpatient prescriber, and what is the date of my first appointment with them?
  5. If I have side effects or a slip after discharge, who do I call, and should I keep taking the medication?

If any answer is “we’ll figure that out later,” ask for it to be resolved before discharge. A slip after treatment is not a reason to stop a medication without speaking to your prescriber; for naltrexone in particular, continuing it can help keep a single drink from becoming a return to heavy drinking.

Where to Find More Help

NIAAA’s Alcohol Treatment Navigator explains how to evaluate providers who offer medications along with behavioral treatment. SAMHSA’s National Helpline at 1-800-662-4357 is free, confidential, and available 24 hours a day, 365 days a year for treatment referrals. For research on how alcohol use disorder affects the brain, the National Institute on Drug Abuse maintains additional resources.

At Bodhi Addiction Treatment in Northern California, medication for alcohol use disorder is discussed with every appropriate client as part of residential care, not treated as an afterthought at discharge. To talk through whether residential treatment and medication support fit your situation, call (877) 328-1968.

If you or someone you love is in crisis or thinking about suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline. If someone is having a seizure, is severely confused, or cannot be woken, call 911.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Medication decisions for alcohol use disorder should be made with a qualified health care provider who knows your full medical history. Never stop drinking abruptly after heavy, prolonged use without medical supervision.

Two women in a couch-based therapy session — trauma-informed residential addiction treatment

A person arrives at residential treatment able to describe their drinking with real precision. How much, what time of day, which store, the exact week it stopped being a choice. Ask what was happening in their life the year before that, and the answers get shorter. Vaguer. Sometimes they change the subject entirely, and sometimes they say the thing out loud for the first time in a decade and then cannot make eye contact for two days.

Post-traumatic stress and substance use travel together often enough that clinicians working in addiction treatment expect to see both. The question in residential care is almost never whether trauma is part of the picture. It is when, and how carefully, to open that door.

What Co-Occurring PTSD and Substance Use Actually Look Like

The overlap is rarely tidy. Someone may describe drinking to fall asleep, because lying down in a quiet dark room is when the memories arrive. Someone else uses stimulants to stay alert and scanning, because feeling relaxed registers as unsafe. A third person cannot name any trigger at all and simply reports that the substance made a constant background hum go quiet.

In the first days of a residential stay, these presentations are easy to misread. Hypervigilance looks like withdrawal anxiety. A startle response to a closing door looks like agitation. Nightmares look like insomnia. Avoidance of the group room looks like poor engagement or a bad attitude. The clinical work early on is largely a work of correct interpretation, and it takes time and repeated contact rather than a single intake questionnaire.

The National Institute of Mental Health and the National Institute on Drug Abuse both describe co-occurring mental health and substance use conditions as common, and as requiring treatment of both conditions rather than one at a time in isolation. That principle is well established. What is less often explained to families is that treating both at once does not mean starting everything on day one.

Week One Belongs to Stabilization

In the first week, most people are not yet in a position to do trauma-focused therapy, and that is not a delay or a dodge. Sleep is fragmented. Appetite is unreliable. Concentration is poor enough that a person may read the same page of a handout three times. Emotions arrive at full volume without the usual dimmer switch. Memory for recent conversation is patchy, which is why the same information often has to be repeated on day two and again on day five.

Stabilization during this period is both medical and practical. Vital signs get checked. Medications are reviewed. A schedule gets learned. The person figures out where the coffee is and which staff member they will actually talk to. None of it looks like deep work, and all of it is the foundation that deep work requires.

The Safety Piece No One Should Skip

This is the point where a warning belongs, because trauma symptoms can make people want to manage withdrawal privately, quickly, and alone.

Withdrawal from alcohol and from benzodiazepines can be medically dangerous. Both carry a risk of seizures, and alcohol withdrawal can progress to delirium tremens, which is a medical emergency. Neither should be attempted without medical supervision, and a benzodiazepine taper in particular needs to be planned and monitored by a prescriber rather than improvised at home. If you or someone you care about is drinking heavily every day or taking benzodiazepines regularly, the safe next step is a medical evaluation before anything is stopped or reduced. You can reach our admissions team at (877) 328-1968 to talk through what a supervised detox would involve.

The Substance Abuse and Mental Health Services Administration maintains national guidance and a treatment locator for people seeking care, and is a reasonable starting point for anyone comparing options outside our area.

Why Opening Trauma Too Early Can Backfire

There is a version of treatment that sounds thorough and is not. A person is asked, in week one, to narrate the worst thing that ever happened to them, often in a group, often with no established relationship with the clinician in the room. The recounting activates everything the substance had been holding down. There are no regulation skills in place yet to bring that activation back down. The person leaves the session flooded.

What happens next is predictable to anyone who has worked a residential floor. Some people shut down for days. Some ask to leave against clinical advice. Some do not relapse in the building but carry the unresolved activation out the door with them at discharge. Opening a wound is not the same as treating it, and an untimed disclosure can leave a person less able to participate in their own care rather than more.

This is not an argument for avoiding trauma. It is an argument for sequence.

Stabilize, Then Build Skills, Then Process

A reasonable arc in residential treatment moves through three broad stages, with the timing individualized rather than fixed to a calendar.

Stabilize. Medical safety, sleep, nutrition, medication review, and basic orientation. Trauma is acknowledged as present and relevant. It is not yet the subject of the session.

Build capacity. Grounding techniques, distress tolerance, sleep routines, and learning to identify what activation feels like in the body before it becomes overwhelming. This stage is where a person collects evidence that they can come down from a spike without using. That single piece of evidence changes what is possible later.

Process, when ready. Structured trauma-focused work with a clinician trained to do it, at a pace the person helps set, with the skills from the previous stage actively in use. For some people this begins during a residential stay. For many it begins in mental health treatment after discharge and continues for months. Both are legitimate outcomes. Neither is a failure of the residential episode.

Readiness here is a clinical judgment, not a milestone a person earns by behaving well. It is reassessed continually, and it can move backward after a hard phone call or a difficult anniversary date.

What Trauma-Informed Care Looks Like in Practice

The phrase gets used loosely, so it is worth describing concretely. In day-to-day terms it means the schedule is predictable and changes are announced rather than sprung. It means staff explain what they are about to do before doing it, including something as routine as taking a blood pressure reading. It means a person is not asked to disclose history in front of a group they met that morning. It means consistency in who a person talks to, because trust is built by repetition and not by intake forms.

It also means noticing what a behavior is doing rather than only what it looks like. Sitting with their back to the wall. Leaving the door open. Declining a roommate. Waking at four in the morning and pacing the hallway. These read as difficulty when they are, more accurately, adaptations that once kept someone safe.

What Families Tend to Notice

Families often report that the person sounds worse on the phone in week two than in week one. Shorter answers. Flat tone. Irritability that can feel like ingratitude after the family worked hard to get them admitted.

This is common, and it is usually not a sign that treatment is failing. Substances were doing regulation work, and the system is recalibrating without them while sleep is still disordered. What helps is low-demand contact. Short calls. No requests to explain progress. No questions about what they are working on in therapy. Presence rather than pressure works better than almost anything else a family can offer in that stretch.

Our editorial process page explains how our clinical content is reviewed, and the American Society of Addiction Medicine publishes criteria that clinicians use to match a person to an appropriate level of care.

Where to Start

If trauma and substance use are both part of the picture, ask any program you are considering a direct question: what is your sequence, and who on staff is trained to do trauma-focused work. A program that treats the two as separate problems handled by separate people at separate times is describing something other than integrated care.

To talk with our admissions team about residential care in Northern California, call (877) 328-1968. We can discuss medical detox needs, timing, and what a stay would realistically look like for your situation.

This article is for educational purposes only and is not medical advice, a diagnosis, or a substitute for evaluation by a qualified healthcare professional. Withdrawal from alcohol or benzodiazepines can be life-threatening and requires medical supervision. If you are experiencing a medical emergency, call 911.